The American Society of Clinical Oncology (ASCO) has announced that the following guidelines, “Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update” and “Germline and Somatic Genomic Testing in Metastatic Prostate Cancer: ASCO Guideline” are now open for public comment. The Metastatic Castration-Resistant Prostate Cancer Guideline, is an update to ASCO’s 2014 […]
The American Gastroenterological Association (AGA) has announced that their latest guideline, the “AGA Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in Immunosuppressed Individuals” is now open for public comment. This guideline, aimed at educating and providing guidance to frontline health practitioners on the prevention and management of Hepatitis B virus reactivation […]
In our latest installment of the Guidelines International Series, we will be looking at the latest guidelines from the International Society on Thrombosis and Haemostasis (ISTH). As the leading global organization in the field of bleeding and clotting disorders, ISTH plays a pivotal role in offering healthcare professionals and researchers worldwide with invaluable educational resources, […]
In this edition of our Guidelines Monographs Series, we will be taking a look at AstraZeneca’s medication dapagliflozin, brand name Farxiga. Initially approved in 2014, Farxiga is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, provided to individuals with diabetes, heart disease, or kidney disease to improve their outcomes. This Guidelines+ Monograph will take a deeper dive […]
On July 2, 2024, the US Food and Drug Administration (FDA) granted approval for Eli Lilly’s Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease. This treatment is recommended for patients in the early stages of the disease, specifically those with mild cognitive impairment or mild dementia, as demonstrated in the clinical trials. Kisunla marks […]
As we prepare for the National Immunization Awareness Month 2024 and upcoming autumn season, we will be conducting a thorough review of the United States Immunization Schedules for both Adults and Children. These crucial recommendations are released annually by the Centers for Disease Control and Prevention (CDC). They offer essential guidance on the recommended schedules […]
Welcome to our succinct summaries of the most recent healthcare news and research. Keep yourself informed with our easily digestible updates sourced from medical media and news outlets. Aspirin Use and Incidence of Colorectal Cancer According to Lifestyle Risk Study Details | Source Impact of Inflammation on Cognitive Function in Patients With Highly Inflammatory Rheumatoid Arthritis […]
The American Academy of Neurology (AAN) has announced that their latest guideline, “Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Update: Report of the AAN Guidelines Subcommittee,” is now open for public comment. This practice guideline offers updated evidence-based conclusions and recommendations on the use of pharmacologic migraine prevention in adults. The primary objective […]
Our Guidelines Rundown Series continues with a new article that delves into the topic of breastfeeding in support of National Breastfeeding Month 2024. To provide guidance and clinical decision-making support on the matter, the Academy of Breastfeeding Medicine has published a comprehensive set of guidelines that address various aspects of breastfeeding, such as nutrition, supplements, […]
A list of all the FDA approved medications in July 2024.
A list of clinical practice guidelines and guideline summaries that were updated or published in July 2024.
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]
In the latest installment of our Guidelines International Series, we will be delving into the latest guidelines from the World Health Organization (WHO). Established in 1948, WHO is a specialized agency of the United Nations (UN) that facilitates collaboration between nations, partners, and individuals to advance global health, ensure global security, and support marginalized populations. […]
In this edition of our Guidelines+ Monographs Series, we will be taking a look at Bristol-Myers Squibb’s medication apixaban, brand name Eliquis. Initially approved in 2012, Eliquis is a factor Xa inhibitor, an anticoagulant used to prevent stroke and systemic embolism in nonvalvular atrial fibrillation, and to treat deep vein thrombosis (DVT) and pulmonary embolism […]
Welcome to the second installment of the Guidelines International Series, where we will be delving into the European Respiratory Society (ERS). ERS stands as the largest respiratory medicine organization in Europe, with members hailing from 160 countries. As the premier membership organization for respiratory professionals, ERS is committed to advancing excellence in the study, research, […]
Our Guidelines Rundown Series continues with a new article dedicated to Sarcoma Awareness Month. Presently, there exists only a limited number of guidelines pertaining to Soft Tissue Sarcoma (STS), as they have only been released by a few medical societies. These guidelines offer recommendations on the management, treatment, and indications for radiation therapy for STS. […]
According to the National Institute on Deafness and Other Communication Disorders (NIDCD), age-related hearing loss (ARHL) or presbycusis is a prevalent condition among aging adults. Approximately 15% of American adults aged 18 and over report experiencing some degree of hearing difficulty, with one in three individuals between the ages of 65 and 74 experiencing hearing […]
This article will examine a number of ideas and top suggestions for incorporating LLMs and AI, including Chatbots like GPT4 or Llama, into your clinical practice guidelines development process and workflows. As I’m sure you’ve heard, AI is improving and expanding rapidly, and that this is a moving target, so we’ll build upon this series […]
The American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) collaborated to develop the Clinical Practice Guideline on the Management of Stimulant Use Disorder (referred to as the Guideline). It was published on November 8, 2023. The Guideline aims to provide evidence-based strategies and clinically informed standards of care for […]
The American College of Obstetricians and Gynecologists (ACOG) and the Centers for Disease Control and Prevention (CDC) have collaborated on a multiyear initiative entitled “Identifying and Managing Obstetric Emergencies in Nonobstetric Settings.” This initiative addresses pregnancy-related emergencies and complications such as cardiomyopathy, preeclampsia, eclampsia, and stroke, as well as mental health conditions that can pose […]
The American Gastroenterological Association (AGA) has announced that their latest guideline, “The AGA Living Guideline: Pharmacological Management of Moderate-To-Severe Ulcerative Colitis,” is now open for public comment. This guideline, aimed at supporting practitioners in the pharmacological management of moderate-to-severe ulcerative colitis (UC), features 14 recommendations designed to guide therapy decisions with a patient-centered approach. Referred […]
The Endocrine Society unveiled its latest guideline, “Vitamin D for the Prevention of Disease,” on June 3rd, 2024. This evidence-based guideline aims to establish clinical guidelines for the use of vitamin D to lower the risk of disease in individuals without established indications for vitamin D treatment or 25(OH)D testing. Recognized for its vital role […]
A list of all the FDA approved medications in June 2024.
A list of clinical practice guidelines and guideline summaries that were updated or published in June 2024.
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]